Los Angeles, CA, United States of America

Jennifer H Elisseeff

This inventor holds 32 USPTO granted patents and 33 published patent applications, plus 7 CIPO patents and 7 EPO patents, primarily in Tissue Engineering. Top assignees: Johns Hopkins University, Buck Institute for Research on Aging, Mayo Foundation for Medical Education and Research. Active years: 2001-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer H Elisseeff. Retrieved from https://idiyas.com/inventor/jennifer-h-elisseeff

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 33)

% Patents Active = 81.3

CIPO Patents = 7 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 3.5

ph-index = 11

Forward Citations = 452(Granted Patents)

Location History:

Boston, MA (US) (2001)
Los Angeles, CA (US) (2016)
Baltimore, MD (US) (2009 - 2024)

Company Filing History:

26 out of 3,803

Johns Hopkins University

patents

4 out of 51

Buck Institute for Research on Aging

patents

4 out of 1,810

Mayo Foundation for Medical Education and Research

patents

4. 4 out of 41

Unity Biotechnology, Inc.

Biomet Manufacturing Corporation

patents

7. 1 out of 8,594

Massachusetts Institute of Technology

patents

8. 1 out of 3,697

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

9. 1 out of 2,029

University System of Maryland

patents

10. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2024

Loading Chart...

Areas of Expertise:

Hyaluronic Acid

Extracellular Matrix

Wound Healing

Biocompatible Hydrogel

Adipose Tissue

Biological Adhesive

Modified Collagen

Drug Delivery

Polymer Networks

Tissue-Biomaterial Integration

Joint Pain Treatment

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11944637 - Biomaterials comprising hyaluronic acid binding peptides and extracellular matrix binding peptides for hyaluronic acid retention and tissue engineering applications (2024-04-02),

2. 11925725 - Extracellular matrix (ECM) mixture and ECM scaffolds made with same (2024-03-12),

3. 11458227 - Compositions and methods for modulating wound healing and regeneration (2022-10-04),

4. 11135240 - Biomaterials comprising hyaluronic acid binding peptides and extracellular matrix binding peptides for hyaluronic acid retention and tissue engineering applications (2021-10-05),

5. 11078461 - Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products (2021-08-03),

6. 10231991 - Biomaterials comprising hyaluronic acid binding peptides and extracellular matrix binding peptides for hyaluronic acid retention and tissue engineering applications (2019-03-19),

7. 10227369 - Short-chain fatty acid hexosamine analogs and their use in tissue engineering applications (2019-03-12),

8. 10130628 - Treatment of joint pain (2018-11-20),

9. 9993472 - Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2 (2018-06-12),

10. 9855266 - Treatment for osteoarthritis by intra-articular administration of a cis-imidazoline (2018-01-02),

11. 9849128 - Unit dose of a cis-imidazoline for treating an osteoarthritic joint by removing senescent cells (2017-12-26),

12. 9795686 - Biomaterials comprising hyaluronic acid binding peptides and bifunctional biopolymer molecules for hyaluronic acid retention and tissue engineering applications (2017-10-24),

13. 9441200 - Compositions and methods for implantation of adipose tissue and adipose tissue products (2016-09-13),

14. 9441080 - Cellulose hydrogel compositions and contact lenses for corneal applications (2016-09-13),

15. 9314531 - Wound healing compositions comprising biocompatible cellulose hydrogel membranes and methods of use thereof (2016-04-19),

Title: The Innovative Contributions of Jennifer H. Elisseeff in Biomaterials

Introduction

Jennifer H. Elisseeff is a prominent inventor based in Los Angeles, CA, recognized for her innovative contributions to biomaterials and tissue engineering. With a remarkable portfolio of 31 patents, her work significantly impacts the fields of medicine and regenerative therapies.

Latest Patents

Among her latest inventions is a patent focused on biomaterials comprising hyaluronic acid binding peptides and extracellular matrix binding peptides for enhancing hyaluronic acid retention and various tissue engineering applications. This invention introduces novel biomaterial compositions and methods that improve the retention of hyaluronic acid (HA), using small HA binding peptides and extracellular matrix (ECM) binding peptides tethered to synthetic biocompatible polymers. This technology enables better binding of HA to tissues such as cartilage, facilitating improved tissue engineering.

Another notable patent involves the development of an extracellular matrix (ECM) mixture and anatomically-shaped ECM scaffolds. These scaffolds can be created through advanced methods such as three-dimensional (3D) printing and injection molding. The ECM mixture comprises a blend of ECM material and polymer material, which can be adjusted in proportions to suit various applications.

Career Highlights

Jennifer has made significant strides in her career, having worked with esteemed institutions such as The Johns Hopkins University and Unity Biotechnology, Inc. Her roles at these organizations have allowed her to advance her research and innovations in biomaterials.

Collaborations

Throughout her career, Jennifer has collaborated with several talented individuals, including Morgana M. Trexler and Jenna L. Graham. These partnerships have fostered a rich environment for innovation and development in biomaterials and tissue engineering.

Conclusion

Jennifer H. Elisseeff's contributions to the field of biomaterials and her numerous patents underscore the importance of innovation in medical science. As she continues to push the boundaries of tissue engineering, her work lays the foundation for future advancements in regenerative medicine.

Profile summary based on public USPTO records.